Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 2 (RPL23AP2)

Target: RPL23AP2
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L23a pseudogene 2 (RPL23AP2) is a processed pseudogene in the human genome. It is a non-functional, non-coding DNA segment related to the ribosomal protein L23a gene but does not code for a functional ribosomal protein[1][7]. Unlike its functional parent gene RPL23A, which encodes a structural component of the large (60S) ribosomal subunit and is involved in protein synthesis, RPL23AP2 does not produce a biologically active protein product and is not associated with molecular functions or therapeutic targeting. There is no evidence suggesting a role for RPL23AP2 in coding proteins, disease, drug interaction, or clinical biomarker use[1][7].

Other names: RPL23AP2Ribosomal protein L23a pseudogene 2

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 2 (RPL23AP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 2 (RPL23AP2).

Explore the full profile